AIMD
Price
$0.63
Change
-$0.02 (-3.08%)
Updated
Jan 17 closing price
Capitalization
6.73M
CODX
Price
$0.80
Change
+$0.02 (+2.56%)
Updated
Jan 17 closing price
Capitalization
34.7M
80 days until earnings call
Ad is loading...

AIMD vs CODX

Header iconAIMD vs CODX Comparison
Open Charts AIMD vs CODXBanner chart's image
Ainos
Price$0.63
Change-$0.02 (-3.08%)
Volume$220.27K
Capitalization6.73M
Co-Diagnostics
Price$0.80
Change+$0.02 (+2.56%)
Volume$74.58K
Capitalization34.7M
AIMD vs CODX Comparison Chart
Loading...
AIMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CODX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AIMD vs. CODX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIMD is a Hold and CODX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (AIMD: $0.63 vs. CODX: $0.80)
Brand notoriety: AIMD and CODX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AIMD: 31% vs. CODX: 31%
Market capitalization -- AIMD: $6.73M vs. CODX: $34.7M
AIMD [@Medical Specialties] is valued at $6.73M. CODX’s [@Medical Specialties] market capitalization is $34.7M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AIMD’s FA Score shows that 0 FA rating(s) are green whileCODX’s FA Score has 1 green FA rating(s).

  • AIMD’s FA Score: 0 green, 5 red.
  • CODX’s FA Score: 1 green, 4 red.
According to our system of comparison, AIMD is a better buy in the long-term than CODX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AIMD’s TA Score shows that 5 TA indicator(s) are bullish while CODX’s TA Score has 3 bullish TA indicator(s).

  • AIMD’s TA Score: 5 bullish, 4 bearish.
  • CODX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, AIMD is a better buy in the short-term than CODX.

Price Growth

AIMD (@Medical Specialties) experienced а -11.90% price change this week, while CODX (@Medical Specialties) price change was -4.23% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.97%. For the same industry, the average monthly price growth was +5.53%, and the average quarterly price growth was +1.10%.

Reported Earning Dates

AIMD is expected to report earnings on Feb 28, 2024.

CODX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Medical Specialties (+0.97% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CODX($34.7M) has a higher market cap than AIMD($6.73M). AIMD YTD gains are higher at: 37.171 vs. CODX (6.000). AIMD has higher annual earnings (EBITDA): -8.75M vs. CODX (-41.48M). CODX has more cash in the bank: 58.5M vs. AIMD (1.89M). CODX has less debt than AIMD: CODX (2.99M) vs AIMD (5.96M). CODX has higher revenues than AIMD: CODX (6.81M) vs AIMD (122K).
AIMDCODXAIMD / CODX
Capitalization6.73M34.7M19%
EBITDA-8.75M-41.48M21%
Gain YTD37.1716.000620%
P/E RatioN/A6.17-
Revenue122K6.81M2%
Total Cash1.89M58.5M3%
Total Debt5.96M2.99M199%
FUNDAMENTALS RATINGS
AIMD vs CODX: Fundamental Ratings
AIMD
CODX
OUTLOOK RATING
1..100
9314
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
52
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
4065
P/E GROWTH RATING
1..100
10020
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AIMD's Valuation (48) in the null industry is in the same range as CODX (52) in the Biotechnology industry. This means that AIMD’s stock grew similarly to CODX’s over the last 12 months.

AIMD's Profit vs Risk Rating (100) in the null industry is in the same range as CODX (100) in the Biotechnology industry. This means that AIMD’s stock grew similarly to CODX’s over the last 12 months.

CODX's SMR Rating (97) in the Biotechnology industry is in the same range as AIMD (98) in the null industry. This means that CODX’s stock grew similarly to AIMD’s over the last 12 months.

AIMD's Price Growth Rating (40) in the null industry is in the same range as CODX (65) in the Biotechnology industry. This means that AIMD’s stock grew similarly to CODX’s over the last 12 months.

CODX's P/E Growth Rating (20) in the Biotechnology industry is significantly better than the same rating for AIMD (100) in the null industry. This means that CODX’s stock grew significantly faster than AIMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AIMDCODX
RSI
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 11 days ago
76%
Bearish Trend 11 days ago
85%
Momentum
ODDS (%)
Bullish Trend 11 days ago
85%
Bullish Trend 11 days ago
86%
MACD
ODDS (%)
N/A
Bullish Trend 11 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 11 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
78%
Bearish Trend 11 days ago
83%
Advances
ODDS (%)
Bullish Trend 13 days ago
79%
Bullish Trend 13 days ago
82%
Declines
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 11 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
90%
Aroon
ODDS (%)
Bullish Trend 11 days ago
64%
Bearish Trend 11 days ago
84%
View a ticker or compare two or three
Ad is loading...
AIMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CODX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OXBR4.320.37
+9.36%
Oxbridge Re Holdings Limited
SGMT4.390.12
+2.81%
Sagimet Biosciences
PACK6.370.05
+0.79%
Ranpak Holdings Corp
CDP29.57-0.21
-0.71%
COPT Defense Properties
PATH13.02-0.33
-2.47%
UiPath

AIMD and

Correlation & Price change

A.I.dvisor tells us that AIMD and CRMD have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AIMD and CRMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AIMD
1D Price
Change %
AIMD100%
-3.77%
CRMD - AIMD
28%
Poorly correlated
-4.85%
XLO - AIMD
26%
Poorly correlated
N/A
LFWD - AIMD
23%
Poorly correlated
-9.39%
RGEN - AIMD
22%
Poorly correlated
-1.44%
CODX - AIMD
21%
Poorly correlated
+2.53%
More

CODX and

Correlation & Price change

A.I.dvisor tells us that CODX and ILMN have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CODX and ILMN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CODX
1D Price
Change %
CODX100%
+2.53%
ILMN - CODX
28%
Poorly correlated
-0.51%
MBOT - CODX
27%
Poorly correlated
-7.87%
ALGN - CODX
26%
Poorly correlated
+2.43%
AEMD - CODX
26%
Poorly correlated
-7.10%
CORBF - CODX
25%
Poorly correlated
-15.83%
More